Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH) remain underrecognized in ambulatory care despite their rising prevalence.
gastroenterology
ambulatory care
acpe topic 01 (disease st mgmt/drug therapy)